Q16* (p.Gln16Ter) variant of TP53 (Cellular tumor antigen p53)
Q16* (p.Gln16Ter) in TP53 (Cellular tumor antigen p53) is a protein-truncating change. Clinical records from EBI and UniProt describe it as uncertain significance in the context of in a sporadic cancer. The record also includes experimental measurements and structural context.
Q16* (p.Gln16Ter) variant details
- p.Gln16Ter
- cosmic curated COSV53806
- Ensembl rs2151047550
- Uncertain significance
- in a sporadic cancer
- Stop Gained
- EBI: Variant of uncertain significance (in a sporadic cancer)
- UniProt: Uncertain significance (in a sporadic cancer)
- Structural context available
- p53 variant effect measured by cell growth: score -3.51